DSpace Repository

Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.

Show simple item record

dc.creator Soulieres, D
dc.creator Ford, J
dc.creator Rabault, B
dc.creator Ressayre-Djaffer, C
dc.creator Gattermann, N
dc.creator Cunningham, M
dc.creator Angelucci, E
dc.creator Turlin, B
dc.creator Canatan, D
dc.creator Mangiagli, A
dc.creator De Sanctis, V
dc.creator Meddeb, B
dc.creator Rose, C
dc.date 2005-11-16T01:00:00Z
dc.date.accessioned 2021-12-03T11:30:57Z
dc.date.available 2021-12-03T11:30:57Z
dc.identifier 7a7f461d-45a9-425e-9bd6-8cdffbe93047
dc.identifier https://avesis.sdu.edu.tr/publication/details/7a7f461d-45a9-425e-9bd6-8cdffbe93047/oai
dc.identifier.uri http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/92861
dc.description
dc.language eng
dc.rights info:eu-repo/semantics/closedAccess
dc.title Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.
dc.type info:eu-repo/semantics/conferenceObject


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account